OSTX Stock Summary and Trading Ideas (Os Therapies | AMEX:OSTX)

OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.

Os Therapies trades on the AMEX stock market under the symbol OSTX.

As of April 1, 2026, OSTX stock price declined to $1.36 with 336,287 million shares trading.

OSTX has a beta of 0.58, meaning it tends to be less sensitive to market movements. OSTX has a correlation of 0.02 to the broad based SPY ETF.

OSTX has a market cap of $47.89 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that OSTX belongs to (by Net Assets): VXF, VTI, IWC.

OSTX has underperformed the market in the last year with a price return of -11.7% while the SPY ETF gained +18.5%. However, in the short term, OSTX had mixed performance relative to the market. It has outperformed in the last 3 months, returning -2.9% vs -3.6% return in SPY. But in the last 2 weeks, OSTX shares have been beat by the market, returning -11.1% compared to an SPY return of -2.1%.

OSTX support price is $1.33 and resistance is $1.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OSTX shares will trade within this expected range on the day.